Healthcare -
Biotechnology - NASDAQ - US
$ 6.385
3.15 %
$ 286 M
Market Cap
-11.82
P/E
YMAB - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities YMAB - Y-mAbs Therapeutics, Inc.
0
LAST VALUE
0.00%
2 YEAR CAGR
14.87%
5 YEAR CAGR
0.00%
10 YEAR CAGR